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Background: Schwannoma is a tumor that develops on peripheral nerves or spinal roots. Although any part of the
body can be affected, axillar and supraclavicular lesions are unusual for schwannoma. We report two cases of
schwannoma arising in the brachial plexus, which were detected by 18F-fluorodeoxyglucose positron emission
tomography and computed tomography (FDG-PET/CT).
Case 1: A 75-year-old Japanese woman showed high FDG accumulation in a subclavicular or axillary lesion found
by FDG-PET/CT. Axillar-subclavicular lymph node metastasis was suspected and surgical excision was performed.
Histological evaluation revealed schwannoma.
Case 2: A 75-year-old Japanese woman was diagnosed with suspected primary lung cancer with brain metastases.
She showed high FDG uptake at a subclavicular or axillary lesion found by FDG-PET/CT. Surgical excision was
performed to arrive at a definitive diagnosis. The mass was located at the trunk of the brachial plexus and was
identified as a schwannoma.
Conclusion: Although schwannoma within an axillar or subclavicular lesion is relatively rare, brachial plexus
schwannoma should be considered in the diagnosis of masses detected by FDG-PET/CT.
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Schwannoma is a relatively rare neoplasm that arises
from Schwann cells of the peripheral nerve sheath [1-3].
Although schwannoma may occur in any organ, includ-
ing the extremities, trunk and head, it rarely appears as
an axillar or supraclavicular lesion.
In recent years, there has been an explosive increase
in the use of positron emission tomography (PET) in
clinical applications. 18F-fluorodeoxyglucose (FDG)-PET
is a noninvasive whole-body imaging technique used to
evaluate various kinds of malignancy, including colorec-
tal cancer and lung cancer, as well as for tumor staging,
restaging, and detection of recurrence, and for monitor-
ing treatment response [4-8]. The FDG-PET technique* Correspondence: ftakaaki@med.gunma-u.ac.jp
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asymptomatic individuals [9-11]. However, schwanno-
mas generally show high FDG uptake [12-14]. We report
here two cases of schwannoma arising in the brachial
plexus detected by FDG-PET and initially suspected to
be axillar or subclavicular lymph node metastasis.Case presentation
Case 1
A 75-year-old Japanese woman was referred to our hos-
pital after high accumulation in a subclavicular or axillary
lesion was found by FDG-PET and computed tomography
(CT) (SUVmax 3.4) (Figure 1). She had been diagnosed
with early rectal cancer and a laparoscopic low anterior
resection had been performed 14 months previously.
Axillar or subclavicular lymph node metastasis from car-
cinoma was suspected, but the differential diagnosis of a
solid mass with FDG uptake by PET/CT in axillar or. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 18F-fluorodeoxyglucose positron emission tomography and computed tomography revealed a mass with abnormal uptake of
fluorodeoxyglucose in the right axillary to subclavicular region.
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coidosis, tuberculosis, and other infections. For treatment
and diagnosis, surgical excision was therefore performed.
The tumor was located at the trunk of the brachial plexus,
and was identified as a schwannoma. Histological evalu-
ation revealed an encapsulated mass composed of spindle-
shaped cells with pointed basophilic nuclei and with nu-
clear palisading arranged in interlacing bundles known as
Verocay bodies (Figure 2). Neither malignancy of the pro-
liferative cells nor invasion was observed. These findings
are compatible with schwannoma. Our follow-up of the
patient has remained uneventful without postoperative
neurological disturbance.Case 2
A 75-year-old Japanese woman showed an abnormal
shadow in the right lung and multiple masses in the
brain, suggesting primary lung cancer with brain metas-
tases. She showed high FDG uptake in a subclavicular or
axillary lesion found by FDG-PET/CT (SUVmax 2.6)
(Figure 3), and the SUVmax of the lung masses was 2.7.
Thus, axillar or subclavicular lymph node metastasis was
suspected and surgical excision was performed to arriveFigure 2 Histological evaluation. (a) Macroscopic view. The tumor is an
evaluation revealed an encapsulated mass composed of spindle-shaped ce
in interlacing bundles known as Verocay bodies.at a definitive diagnosis. The mass was located at the
trunk of the brachial plexus, and was identified as a
schwannoma (Figure 4). Surgical resection was not per-
formed because injury to the brachial plexus sometimes
leads to postoperative neurological disturbance. In this
case, because findings at the surgery indicated that the
mass was located at the trunk of the brachial plexus,
strongly suggesting schwannoma, we did not perform re-
section. The patient was diagnosed with primary lung
cancer by thoracoscopic surgery.Discussion
The FDG-PET technique has been widely used with high
accuracy for staging and identifying recurrence in vari-
ous types of cancer [15,16]. Ueda et al. demonstrated
that the diagnostic accuracy of FDG-PET/CT for axillary
lymph node metastasis in cases with breast cancer was
83%, with 58% sensitivity and 95% specificity [17]. Thus,
the false-positive diagnostic rate of FDG-PET/CT ap-
pears to be low and FDG-PET is useful for the detection
and localization of schwannoma [12-14]. Schwannoma is
a tumor that develops on peripheral nerves or spinal
roots [1]. The most common locations are the neck,encapsulated mass with a soft and elastic consistency. (b) Histological
lls with pointed basophilic nuclei and with nuclear palisading arranged
Figure 3 18F-fluorodeoxyglucose positron emission tomography and computed tomography revealed a mass with abnormal uptake of
fluorodeoxyglucose in the left axillary to subclavicular region.
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mediastinum, and stomach [2,3], while axillar and supra-
clavicular lesions are unusual [16,18,19]. The differential
diagnosis of a solid mass with FDG uptake by PET/CT
in axillar or subclavicular lesions includes lymph node
metastasis from carcinoma, malignant lymphoma, sar-
coidosis, tuberculosis, and other infections. The distinc-
tion of schwannoma in axillary or subclavicular lesions
from lymph node metastasis may be difficult. Previous
reports have discussed schwannoma cases misdiagnosed
as axillary node metastasis in breast cancer patients
[18,19]. In the present cases, PET/CT also failed to
distinguish schwannoma from lymph node metastasis.
Schwannoma arising in the brachial plexus should be
included in the differential diagnosis of masses in the
axillar or subclavicular region detected by FDG-PET.
Supraclavicular lymph node metastasis is often encoun-
tered in patients with lung cancer; however, axillary
lymph node metastasis from lung cancer or colon cancer
appears to be very rare [20,21], and the status of the
primary lesion should be taken into consideration for
the diagnosis.
In Case 2, we did not resect the mass. In cases of
schwannoma, resection is performed only if the lesion
is symptomatic, moderately large, or exhibits rapidFigure 4 The mass was located at the trunk of the brachial
plexus, and was identified as a schwannoma.growth. Furthermore, it is necessary to pay close atten-
tion to irreversible complications that may arise from
resection in the brachial plexus. In this case, because
findings during surgery indicated that the mass was
located at the trunk of the brachial plexus, strongly
suggesting schwannoma, in conjugation with the find-
ings and experience of Case 1, we did not perform
resection. When a connection with the brachial plexus
is confirmed, resection should be avoided if there are
no symptoms.
Conclusion
We report two cases of schwannoma arising in the bra-
chial plexus and mimicking lymph node metastasis,
identified by FDG-PET/CT. Although schwannoma in
an axillar or subclavicular lesion is relatively rare, bra-
chial plexus schwannoma should be considered in the
diagnosis of masses detected by FDG-PET.
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